智通财经APP讯，麦科医药-B(02335)于2026年6月15-2026年6月18日招股，拟全球发售5805.44万股H股，香港公开发售580.56万股（可与重新分配），国际发售5224.88万股（可与重新分配），另有15%超额配股权。每股发售价18.2-21港元，每手200股，预期H股将于2026年6月24日(星期三)上午九时正开始在联交所买卖。
智通财经APP讯，麦科医药-B(02335)于2026年6月15-2026年6月18日招股，拟全球发售5805.44万股H股，香港公开发售580.56万股（可与重新分配），国际发售5224.88万股（可与重新分配），另有15%超额配股权。每股发售价18.2-21港元，每手200股，预期H股将于2026年6月24日(星期三)上午九时正开始在联交所买卖。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.